Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan
By Vince Sullivan · November 20, 2023, 7:11 PM EST
Drug company RevitaLid Pharmaceutical Corp. received court approval Monday for its prepackaged Chapter 11 plan that will swap $80 million of its prepetition secured debt for most of the equity in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login